celastrol has been researched along with 1-naphthylisothiocyanate in 1 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (1-naphthylisothiocyanate) | Trials (1-naphthylisothiocyanate) | Recent Studies (post-2010) (1-naphthylisothiocyanate) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 414 | 0 | 142 |
| Protein | Taxonomy | celastrol (IC50) | 1-naphthylisothiocyanate (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 1 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 6.272 | |
| Adenosine receptor A3 | Homo sapiens (human) | 6.1 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 6.1 | |
| C-C chemokine receptor type 2 | Homo sapiens (human) | 6.699 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 6.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, WM; Cheng, Y; Gonzalez, FJ; Hu, DD; Hu, JP; Jiang, T; Li, F; Liu, F; Tang, YM; Xiao, XR; Yang, JH; Zhao, Q | 1 |
1 other study(ies) available for celastrol and 1-naphthylisothiocyanate
| Article | Year |
|---|---|
Celastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR Signaling.
Topics: 1-Naphthylisothiocyanate; Adult; Animals; Cholestasis, Intrahepatic; Disease Models, Animal; Female; Gene Expression Profiling; Humans; Male; Metabolomics; Mice; Middle Aged; Pentacyclic Triterpenes; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Sirtuin 1; Thioacetamide; Treatment Outcome; Triterpenes | 2019 |